High-dose intravenous vitamin C decreases rates of mechanical ventilation and cardiac arrest in severe COVID-19

Intravenous vitamin C (IV-VitC) has been suggested as a treatment for severe sepsis and acute respiratory distress syndrome; however, there are limited studies evaluating its use in severe COVID-19. Efficacy and safety of high-dose IV-VitC (HDIVC) in patients with severe COVID-19 were evaluated. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Andrea L., Halalau, Alexandra, Dokter, Jonathan J., Paydawy, Tania S., Karabon, Patrick, Bastani, Aveh, Baker, Rebecca E., Balla, Abdalla Kara, Galens, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
EM - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961256/
https://www.ncbi.nlm.nih.gov/pubmed/35349005
http://dx.doi.org/10.1007/s11739-022-02954-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961256/
https://www.ncbi.nlm.nih.gov/pubmed/35349005
http://dx.doi.org/10.1007/s11739-022-02954-6

Ejemplares similares